S&P 500 (NYSE:SPY) component Abbott Laboratories (NYSE:ABT) will unveil its latest earnings on Wednesday, April 18, 2012. Abbott Laboratories is a pharmaceuticals health care company, whose main line of business is in the discovery, development, manufacture, and sale of a broad range of health care products. Its customers include wholesalers, hospitals and commercial laboratories.
Abbott Laboratories Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for net income of 99 cents per share, a rise of 8.8% from the company’s actual earnings for the year-ago quarter. During the past three months, the average estimate has moved down from $1.04. Between one and three months ago, the average estimate moved down. It has been unchanged at 99 cents during the last month. Analysts are projecting profit to rise by 7.7% compared to last year’s $5.03.
Past Earnings Performance: Last quarter, the company beat estimates by one cent, coming in at profit of $1.45 a share versus the estimate of net income of $1.44 a share. It marked the fourth straight quarter of beating estimates.
Investing Insights: What’s the Future of Microsoft’s Stock?
Wall St. Revenue Expectations: Analysts predict a rise of 3.4% in revenue from the year-earlier quarter to $9.35 billion.
Analyst Ratings: Optimism surrounds Abbott Laboratories Com Stk NPV, as 10 analysts rate it as a buy, none rate it as a sell, and 10 rate it as a hold.
A Look Back: In the fourth quarter of the last fiscal year, profit rose 12.3% to $1.62 billion ($1.03 a share) from $1.44 billion (92 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 4.1% to $10.38 billion from $9.97 billion.
On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 17.4% in the first quarter of the last fiscal year, 9% in the second quarter of the last fiscal year and 13.2% in the third quarter of the last fiscal year before increasing again in the fourth quarter of the last fiscal year of the last fiscal year.
Stock Price Performance: Between February 14, 2012 and April 12, 2012, the stock price had risen $5.11 (9.4%), from $54.61 to $59.72. The stock price saw one of its best stretches over the last year between March 7, 2012 and March 20, 2012, when shares rose for 10 straight days, increasing 7.4% (+$4.11) over that span. It saw one of its worst periods between July 22, 2011 and August 2, 2011 when shares fell for eight straight days, dropping 5.2% (-$2.68) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories: